Lipocine (LPCN)
Develops oral therapies and licenses approved testosterone product TLANDO to commercialization partners.
$2.15
vs last close−0.01 (−0.46%)
Something off on this page? Send us feedback.
13F · 13D/G · Form 4
| Institutions | 36.15% | 2.98M shares | |
|---|---|---|---|
| 36 holders · as of Jun 30, 2026 | |||
| Insiders | 4.42% | 364.5K shares | |
| 2 holders · as of Apr 7, 2026 | |||
| Other | 59.43% | 4.90M shares | |
| remainder | |||
8.24M company shares as of Sep 23, 2026 · institutions as of Jun 30, 2026 · holders as of their latest filing
13F, as of Jun 30, 2026
36 holders · 2.98M shares · 4 new positions · 18 increased · 3 reduced · 14 closed
| Holder | Shares | % outstanding | Chg q/q | Filed |
|---|---|---|---|---|
| Squadron Capital Management LLC | 810.0K | 9.83% | +360.0K | Aug 14, 2026 |
| Ikarian Capital, LLC | 508.6K | 6.17% | 0 | Aug 14, 2026 |
| Eversept Partners, LP | 295.0K | 3.58% | 0 | Aug 14, 2026 |
| Vanguard Capital Management LLC | 230.8K | 2.80% | +30.2K | Aug 13, 2026 |
| Acadian Asset Management LLC | 170.4K | 2.07% | +170.4Knew | Aug 13, 2026 |
| Boothbay Fund Management, LLC | 140.5K | 1.70% | 0 | Aug 14, 2026 |
| Jane Street Group, LLC | 95.2K | 1.16% | +75.2K | Aug 14, 2026 |
| BlackRock, Inc. | 89.3K | 1.08% | 0 | Aug 7, 2026 |
13D/G · 5% or more, as filed
| Holder | % of class | Shares | Form | Filed |
|---|---|---|---|---|
| Ikarian Capital, LLC | 6.30% | 508.6K | 13G | May 15, 2026 |
| Squadron Master Fund LP | 6.20% | 450.0K | 13G | May 15, 2026 |
Form 4
Latest trades
| Date | Insider | Type | Shares | Avg price | Owned after |
|---|---|---|---|---|---|
| Apr 7, 2026 | John W. Higuchidirector | Purchase | 40,000 | $2.03 | 203,797 |
| Apr 6, 2026 | Mahesh V. Pateldirector, officer: Chief Executive Officer | Purchase | 25,000 | $2.03 | 160,679 |
| Apr 6, 2026 | John W. Higuchidirector | Purchase | 123,000 | $2.05 | 163,797 |
| Apr 2, 2026 | Mahesh V. Pateldirector, officer: Chief Executive Officer | Purchase | 25,000 | $2.02 | 135,679 |
House and Senate disclosures
Not reported.